Rhode Island leaders spotlight life sciences at NEMIC pitch event

Rhode Island Governor-elect Helena Foulkes and U.S. Rep. Gabe Amo appeared at NEMIC’s fall pitch event in Providence on Nov. 5, signaling growing state and federal attention to healthcare innovation. The visit highlights how life sciences are becoming a bigger part of Rhode Island’s economic strategy as the state looks to turn research and startups into jobs and commercial growth.

Why it matters: - Rhode Island is trying to strengthen its life sciences economy and turn healthcare innovation into jobs, investment and commercial growth. - The appearance of Governor-elect Helena Foulkes and U.S. Rep. Gabe Amo put public attention on that effort two days after Foulkes won the governor’s race. - Their presence signaled that the next phase of Rhode Island’s economic strategy may include deeper support for startups, research translation and industry partnerships.

What happened: - Helena B. Foulkes and Gabe Amo attended the New England Medical Innovation Center’s 2026 Fall Pitch Event on Nov. 5 in Providence. - The event brought together entrepreneurs, industry leaders and innovators working in healthcare technology. - The visit came 48 hours after Rhode Island voters elected Foulkes as governor-elect. - Foulkes has a healthcare and business background, including serving as president of CVS Pharmacy. - Amo’s role in Congress links Rhode Island’s economic priorities with federal opportunities in Washington.

The details: - NEMIC is a Rhode Island-based 501(c)(3) nonprofit focused on strengthening the healthcare innovation and life sciences ecosystem. - The organization helps innovators move from concept to commercialization through commercialization support, workforce development, industry partnerships, expert advising and entrepreneurial programming. - NEMIC works as a neutral nonprofit partner across entrepreneurs, investors, healthcare organizations, academic institutions, industry experts and public-sector stakeholders. - The group says it has supported more than 515 startups. - NEMIC says its work has contributed to the creation of 367 high-value jobs. - The organization says its supported innovations have affected more than 120,000 lives. - NEMIC has been operating for 9 years. - The organization’s role is to help close the gap between promising technology and market success, including investment, regulatory approval, clinical adoption and patient impact.

Between the lines: - Rhode Island already has healthcare institutions, academic research, technical expertise and entrepreneurial talent, but those assets do not automatically turn into companies or jobs. - The event suggested growing agreement that the state needs a more connected innovation pipeline if it wants to compete regionally and nationally. - Foulkes’ early appearance with the innovation community suggests the incoming administration may treat life sciences as a near-term priority. - Amo’s attendance reinforced the idea that federal support and policy connections could matter for local commercialization efforts.

What's next: - NEMIC said it will continue working with Rhode Island’s incoming leadership and the broader ecosystem to expand commercialization opportunities and investment. - The organization wants stronger ties between industry and academia, more pathways into high-value careers and continued support for companies moving from idea to market. - The key question is whether the attention around the event leads to new partnerships, investment and sustained policy support for healthcare innovation in Rhode Island.

The bottom line: - Rhode Island’s life sciences push is moving from aspiration to politics, and the governor-elect’s early appearance at NEMIC suggests the issue is now squarely on the state’s economic agenda.